ArticleThe journal of allergy and clinical immunology. Global2026
WDEIA case series: Do unique clinical presentations suggest mechanistic differences?
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Wheat-dependent exercise-induced anaphylaxis (WDEIA) is a rare but potentially severe delayed-onset food allergy occurring exclusively when wheat ingestion is accompanied by augmenting cofactors. Objective: This study aimed to characterize WDEIA, understand its varied clinical presentations, and propose mechanistic differences from classic food allergy. Methods: A retrospective chart review of patients diagnosed with WDEIA between 2017 and 2024 was performed in accordance with the Declaration of Helsinki. The clinical presentation, diagnosis, management strategies, and clinical course were analyzed. Results: The cohort consisted of 7 patients, aged 21 to 46 years (6 male and 1 female). All patients had multiple episodes of severe/Brown grade III anaphylaxis before presentation. As expected with WDEIA, all patients tolerated exercise/other cofactors and wheat independently, although they all reported rare, mild intermittent urticaria that was correlated with wheat ingestion and resolved with antihistamines. Predominant cardiovascular symptoms (including loss of consciousness) with minimal respiratory involvement was noted in all patients. The severity of the anaphylactic shock appeared consistent across all patients regardless of the intensity of exercise, and amongst the different cofactors including alcohol, nonsteroidal anti-inflammatory drugs, and menstruation. Exercise was the most common cofactor in 7 of 7 patients. No correlation of omega-5 gliadin, wheat, or gluten IgE levels with anaphylaxis severity was noted. In all patients, a gluten-free diet prevented both intermittent urticaria and anaphylaxis, whereas separation of gluten from exercise and other cofactors prevented anaphylaxis only, and not intermittent urticaria in those patients. Conclusion: The study confirms the varied presentations of WDEIA, which are distinct from those of classic food allergies, suggesting a different mechanism. The differential effectiveness of the 2 preventive strategies was examined, with a gluten-free diet being the most effective in preventing anaphylaxis and intermittent urticaria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.